The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $39.02

Today's change+0.57 +1.48%
Updated August 26 11:13 AM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $39.02

Today's change+0.57 +1.48%
Updated August 26 11:13 AM EDT. Delayed by at least 15 minutes.

Sanofi SA up (U.S.)$0.57

Sanofi SA is up today by (U.S.)$0.57 or 1.48% to (U.S.)$39.02. Over the last five days, shares have lost 1.64% and sit 4.30% above their 52-week low. This security has underperformed the S&P 500 by 33.10% during the last year.

Key company metrics

  • Open(U.S.) $38.91
  • Previous close(U.S.) $38.45
  • High(U.S.) $39.20
  • Low(U.S.) $38.51
  • Bid / Ask(U.S.) $39.01 / (U.S.) $39.02
  • YTD % change-8.51%
  • Volume879,636
  • Average volume (10-day)1,798,708
  • Average volume (1-month)1,766,394
  • Average volume (3-month)2,122,560
  • 52-week range(U.S.) $37.41 to (U.S.) $51.88
  • Beta1.01
  • Trailing P/E21.78×
  • P/E 1 year forward9.47×
  • Forward PEG1.48×
  • Indicated annual dividend(U.S.) $1.66
  • Dividend yield4.26%
  • Trailing EPS(U.S.) $1.79
Updated August 26 11:13 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.00%

Based on its net profit margin of 12.00%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.67%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue16,2367,92817,8799,680
Total other revenue--------
Total revenue16,2367,92817,8799,680
Gross profit11,2665,48112,2286,682
Total cost of revenue4,9702,4475,6512,998
Total operating expense13,6586,77415,5397,725
Selling / general / administrative4,6092,2124,7282,461
Research & development2,5141,2352,6771,355
Depreciation / amortization8774441,149598
Interest expense (income), net operating--------
Unusual expense (income)6915001,200267
Other operating expenses, total-3-6413446
Operating income2,5781,1542,3401,955
Interest income (expense), net non-operating-102---118--
Gain (loss) on sale of assets--------
Other--------
Income before tax2,3991,0372,2101,850
Income after tax1,9029202,1931,578
Income tax, total49711717272
Net income2,2451,0871,9621,628
Total adjustments to net income--------
Net income before extra. items1,9599872,1951,628
Minority interest-41-26-42-23
Equity in affiliates98934473
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9599872,1951,628
Inc. avail. to common incl. extra. items2,2451,0871,9621,628
Diluted net income2,2451,0871,9661,628
Dilution adjustment----4--
Diluted weighted average shares1,2971,2881,3191,313
Diluted EPS excluding extraordinary itemsvalue per share1.510.771.671.24
Dividends per sharevalue per share0.000.002.930.00
Diluted normalized EPSvalue per share1.931.112.571.41